DexCom Inc. Daily Stock Analysis

Daily Stock Analysis, DXCM, DexCom Inc, priceseries

DexCom Inc. Daily Stock Analysis
Stock Information
Open
436.69
Close
420.81
High
439.77
Low
418.96
Previous Close
432.06
Daily Price Gain
-11.25
YTD High
532.79
YTD High Date
Jan 3, 2022
YTD Low
365.73
YTD Low Date
Feb 24, 2022
YTD Price Change
-99.98
YTD Gain
-19.20%
52 Week High
659.45
52 Week High Date
Nov 18, 2021
52 Week Low
318.45
52 Week Low Date
May 13, 2021
52 Week Price Change
68.75
52 Week Gain
19.53%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 10. 2017
67.04
Jan 30. 2017
78.81
13 Trading Days
17.55%
Link
LONG
Jun 12. 2017
71.68
Jun 27. 2017
75.27
11 Trading Days
5.01%
Link
LONG
Nov 2. 2017
47.72
Dec 11. 2017
58.62
26 Trading Days
22.85%
Link
LONG
Mar 20. 2018
65.59
Apr 6. 2018
70.29
12 Trading Days
7.17%
Link
LONG
May 2. 2018
74.31
Jun 7. 2018
89.89
25 Trading Days
20.97%
Link
LONG
Aug 16. 2018
128.31
Sep 14. 2018
141.98
20 Trading Days
10.66%
Link
LONG
Nov 6. 2018
132.92
Nov 14. 2018
140.00
6 Trading Days
5.32%
Link
LONG
Jan 7. 2019
129.95
Jan 24. 2019
144.39
12 Trading Days
11.11%
Link
LONG
Jun 7. 2019
125.98
Jun 25. 2019
145.33
12 Trading Days
15.36%
Link
LONG
Aug 15. 2019
158.53
Sep 4. 2019
170.96
13 Trading Days
7.84%
Link
LONG
Nov 7. 2019
194.70
Dec 9. 2019
220.95
21 Trading Days
13.48%
Link
LONG
Feb 13. 2020
252.21
Feb 26. 2020
280.91
8 Trading Days
11.38%
Link
LONG
Mar 24. 2020
236.21
Apr 7. 2020
256.82
10 Trading Days
8.73%
Link
LONG
Apr 14. 2020
280.67
Apr 28. 2020
315.58
10 Trading Days
12.44%
Link
LONG
May 1. 2020
341.52
May 20. 2020
400.91
13 Trading Days
17.39%
Link
LONG
Jan 28. 2021
366.89
Feb 12. 2021
387.89
11 Trading Days
5.72%
Link
LONG
Mar 31. 2021
359.39
Apr 30. 2021
400.00
21 Trading Days
11.30%
Link
LONG
May 26. 2021
354.69
Jul 15. 2021
434.69
34 Trading Days
22.56%
Link
LONG
Oct 28. 2021
570.32
Nov 10. 2021
620.89
9 Trading Days
8.87%
Link
Company Information
Stock Symbol
DXCM
Exchange
NasdaqGS
Company URL
http://www.dexcom.com
Company Phone
8582000200
CEO
Kevin Ronald Sayer
Headquarters
California
Business Address
6340 SEQUENCE DRIVE, SAN DIEGO, CA 92121
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0001093557
About

DexCom, Inc. is a medical device manufacturing company. The company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. Its products include Dexcom G4 PLATINUM System, Dexcom studio and Mobile apps. The company was founded by John F. Burd in May 1999 and is headquartered in San Diego, CA.

Description

DexCom, Inc., a medical device company, together with its subsidiaries, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its products include DexCom G4 PLATINUM system for continuous use by adults with diabetes; DexCom G4 PLATINUM with Share, a remote monitoring system; and DexCom G5 Mobile, a CGM system that directly communicates to a patient's mobile and its data can be integrated with DexCom CLARITY, which is a next generation cloud-based reporting software for personalized, easy-to-understand analysis of trends to improve diabetes management. The company also offers sensor augmented insulin pumps. It has a collaboration and license agreement with Verily Life Sciences LLC to develop a series of next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. The company was founded in 1999 and is headquartered in San Diego, California.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading